OpGen【OPGN】株式ニュース

名称	銘柄コード	市場	種別
OpGen Inc	OPGN	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.08	-2.78%	2.80	00:40:20

始値	安値	高値	終値	前日終値
2.78	2.65	2.82		2.88

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/04	05:01	EDGAR2	Form 8-K - Current report
2024/5/31	05:30	EDGAR2	Form 8-K/A - Current report: [Amend]
2024/5/25	05:30	EDGAR2	Form 8-K - Current report
2024/5/25	05:05	GLOBE	OpGen Receives Expected Nasdaq Notice Regarding Delayed Form..
2024/5/23	05:15	EDGAR2	Form 8-K - Current report
2024/5/18	06:02	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
2024/5/16	20:00	GLOBE	OpGen Announced 1-for-10 Reverse Stock Split
2024/5/15	05:30	EDGAR2	Form 8-K - Current report
2024/4/30	05:05	GLOBE	OpGen Provides Update on Business Operations and Strategic..
2024/4/24	05:15	GLOBE	OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
2024/3/27	05:20	APS	Shares Rip In Reaction To Activist Investor Becoming CEO
2024/3/26	05:05	GLOBE	OpGen Announces Acquisition of Preferred Stock by David..
2024/2/14	06:30	EDGAR2	Form 8-K - Current report
2024/2/08	21:30	EDGAR2	Form 8-K - Current report
2024/1/10	06:30	EDGAR2	Form 8-K - Current report
2023/12/13	06:58	EDGAR2	Form 8-K - Current report
2023/12/06	06:37	EDGAR2	Form 8-K - Current report
2023/11/24	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2023/11/15	06:30	GLOBE	OpGen Reports Third Quarter 2023 Financial Results and..
2023/11/14	06:59	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2023/11/08	06:30	EDGAR2	Form 8-K - Current report
2023/10/27	05:30	EDGAR2	Form 8-K - Current report
2023/10/17	05:30	EDGAR2	Form 8-K - Current report
2023/10/14	06:18	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/14	06:17	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/14	06:15	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/14	06:14	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/14	06:13	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/13	01:32	GLOBE	OpGen Enters Into Warrant Inducement Transaction for up to..
2023/10/12	05:40	EDGAR2	Form 8-K - Current report
2023/10/12	05:30	EDGAR2	Form 8-K - Current report
2023/9/29	05:24	EDGAR2	Form RW - Registration Withdrawal Request
2023/9/09	05:30	EDGAR2	Form 8-K - Current report
2023/9/08	05:30	EDGAR2	Form 8-K - Current report
2023/8/14	21:45	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/11	05:31	EDGAR2	Form 8-K - Current report
2023/8/11	05:15	GLOBE	OpGen Reports Second Quarter 2023 Financial Results and..
2023/8/07	20:30	GLOBE	OpGen’s Subsidiary Ares Genetics Releases New Features to..
2023/8/03	21:00	GLOBE	OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration..
2023/8/03	20:30	GLOBE	OpGen to Provide Business Update and Financial Results for..
2023/8/01	22:40	EDGAR2	Form DEF 14A - Other definitive proxy statements
2023/7/22	05:55	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2023/7/19	20:30	GLOBE	OpGen’s Subsidiary Curetis Meets Milestones of Extended and..
2023/7/15	05:30	EDGAR2	Form S-1 - General form for registration of securities under..
2023/7/06	05:30	EDGAR2	Form 8-K - Current report
2023/7/01	05:30	EDGAR2	Form 8-K - Current report
2023/6/26	20:30	GLOBE	OpGen Subsidiary Ares Genetics Successfully Maintains Key..
2023/6/22	20:30	GLOBE	OpGen’s Subsidiary Curetis Receives Batch of Ten New..
2023/6/20	20:30	GLOBE	OpGen Presents Unyvero Urinary Tract Infection Panel Trial..